Lobbying Update: $70,000 of JOHN DEERE lobbying was just disclosed

$70,000 of JOHN DEERE lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Right to repair."

You can find more data on corporate lobbying on Quiver Quantitative.

DE Congressional Stock Trading

Members of Congress have traded $DE stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $DE stock by members of Congress over the last 6 months:

• REPRESENTATIVE RICK W. ALLEN sold up to $15,000 on 08/14.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

DE Hedge Fund Activity

We have seen 858 institutional investors add shares of DE stock to their portfolio, and 1,002 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• PRICE T ROWE ASSOCIATES INC /MD/ added 2,725,148 shares (+98.4%) to their portfolio in Q3 2024, for an estimated $1,137,286,014
• WELLINGTON MANAGEMENT GROUP LLP added 1,782,984 shares (+32.0%) to their portfolio in Q3 2024, for an estimated $744,092,712
• JPMORGAN CHASE & CO removed 1,596,184 shares (-14.1%) from their portfolio in Q3 2024, for an estimated $666,135,468
• JANUS HENDERSON GROUP PLC removed 1,430,035 shares (-39.9%) from their portfolio in Q3 2024, for an estimated $596,796,506
• MORGAN STANLEY removed 1,103,538 shares (-20.4%) from their portfolio in Q3 2024, for an estimated $460,539,513
• FMR LLC added 988,380 shares (+27.8%) to their portfolio in Q3 2024, for an estimated $412,480,625
• PATHWAY FINANCIAL ADVISERS, LLC added 852,885 shares (+53338.6%) to their portfolio in Q3 2024, for an estimated $355,934,497

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.